These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 1848303)

  • 1. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
    Wang F; Marchini A; Kieff E
    J Virol; 1991 Apr; 65(4):1701-9. PubMed ID: 1848303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.
    Marchini A; Longnecker R; Kieff E
    J Virol; 1992 Aug; 66(8):4972-81. PubMed ID: 1321281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus recombinants from overlapping cosmid fragments.
    Tomkinson B; Robertson E; Yalamanchili R; Longnecker R; Kieff E
    J Virol; 1993 Dec; 67(12):7298-306. PubMed ID: 8230453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant.
    Marchini A; Cohen JI; Wang F; Kieff E
    J Virol; 1992 May; 66(5):3214-9. PubMed ID: 1313925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.
    Tomkinson B; Kieff E
    J Virol; 1992 Feb; 66(2):780-9. PubMed ID: 1309912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
    Rooney C; Howe JG; Speck SH; Miller G
    J Virol; 1989 Apr; 63(4):1531-9. PubMed ID: 2538644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
    Robertson ES; Tomkinson B; Kieff E
    J Virol; 1994 Mar; 68(3):1449-58. PubMed ID: 8107208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells.
    Lupton S; Levine AJ
    Mol Cell Biol; 1985 Oct; 5(10):2533-42. PubMed ID: 3016506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial elimination of Epstein-Barr virus plasmids from Burkitt's lymphoma cells by transfecting the BZLF1 gene.
    Takada K; Ji Z; Fujiwara S; Shimizu N; Tanabe-Tochikura A
    J Virol; 1992 Sep; 66(9):5590-3. PubMed ID: 1323712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of Epstein-Barr virus-infected clones of the human T-cell line MT-2: use of recombinant viruses with a positive selection marker.
    Fujiwara S; Ono Y
    J Virol; 1995 Jun; 69(6):3900-3. PubMed ID: 7745743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
    J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
    Mannick JB; Cohen JI; Birkenbach M; Marchini A; Kieff E
    J Virol; 1991 Dec; 65(12):6826-37. PubMed ID: 1658376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
    J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain.
    Trivedi P; Spinsanti P; Cuomo L; Volpe M; Takada K; Frati L; Faggioni A
    J Virol; 2001 May; 75(10):4929-35. PubMed ID: 11312367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    Cohen JI; Wang F; Kieff E
    J Virol; 1991 May; 65(5):2545-54. PubMed ID: 1850028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
    Murray RJ; Young LS; Calender A; Gregory CD; Rowe M; Lenoir GM; Rickinson AB
    J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An EBNA-negative, EBV-genome-positive human lymphoblast cell line in which superinfecting EBV DNA is not maintained.
    Reisman D; Sugden B
    Virology; 1984 Aug; 137(1):113-26. PubMed ID: 6089410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.
    Contreras-Salazar B; Ehlin-Henriksson B; Klein G; Masucci MG
    J Virol; 1990 Nov; 64(11):5441-7. PubMed ID: 2170681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.